MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Comprehensive clinico-pathophysiological assessment of constipation in Parkinson’s disease

E. de Pablo-Fernandez, V. Passananti, N. Zárate-López, A. Emmanuel, T. Warner (London, United Kingdom)

Meeting: 2019 International Congress

Abstract Number: 846

Keywords: Constipation, Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To perform a comprehensive assessment of constipation in Parkinson’s disease (PD) using various complementary diagnostic techniques to elucidate its pathophysiology and improve its symptomatic management

Background: Despite the contribution to the non-motor clinical burden and potential role in PD pathogenesis, the pathophysiological mechanisms of constipation in PD are poorly understood.

Method: Patients with a diagnosis of PD according to the UK Brain Bank criteria and complaints of constipation were recruited from a PD specialist clinic between 2016-2018. Demographic and clinical features of PD and medications were recorded. Participants were evaluated with validated clinical questionnaires to assess constipation severity, colonic transit studies, high-resolution anorectal manometry and MRI defecography.

Results: 42 patients (69% male; age 68 ± 8 years; disease duration 11 ± 6 years) were included. 33 (78.6%) had objective constipation defined by < 3 bowel movements/week or straining. Severity of constipation correlated with severity of disease (HY stage), motor (MDS-UPDRS) and non-motor symptoms (NMSQ) but not with age, disease duration or PD medications. 15 patients underwent assessment of slow transit and anorectal function (high-resolution anorectal manometry and/or MRI defecography). A combination of both delayed colonic transit and anorectal dysfunction was the pattern most commonly found (60%) and overall anorectal dysfunction was more prevalent than isolated slow transit constipation. Abnormal physiological findings were heterogeneous including reduced colonic motility, rectal hyposensitivity and defecatory dyssynergia.

Conclusion: Multiple complex overlapping pathophysiological mechanisms are responsible of constipation in PD. Several complementary investigations are required for a systematic assessment and symptomatic management should be guided by the underlying pathophysiological abnormalities in those with refractory symptoms.

References: Fasano A, Visanji NP, Liu, LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 2015;14(6):625-639. Knudsen K, Krogh K, Ostergaard K, Borghammer P. Constipation in Parkinson’s disease: Subjective symptoms, objective markers, and new perspectives. Mov Disord 2017;32(1):94-105.

To cite this abstract in AMA style:

E. de Pablo-Fernandez, V. Passananti, N. Zárate-López, A. Emmanuel, T. Warner. Comprehensive clinico-pathophysiological assessment of constipation in Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/comprehensive-clinico-pathophysiological-assessment-of-constipation-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/comprehensive-clinico-pathophysiological-assessment-of-constipation-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley